Waters Rankings 2015: Best Cloud-Based Services Provider ─ Enfusion

Enfusion operates out of three offices globally in New York, Chicago and London.

dsc-0940-app
Joseph Vayalattu, Earl Monroe and John Auerbach

The beauty of cloud-based solutions is that they can be delivered remotely to any location in the world, and with three offices-Chicago, New York and London-Enfusion has clearly embraced this concept wholeheartedly. Primarily targeted at hedge funds and alternative investment managers, the Integráta platform is a portfolio and order management system delivered as a fully hosted solution, covering the entire operational life cycle of investment management and trading activities. According to the firm, its global client base holds more than $90 billion of assets under management-not huge by any measure, but a remarkable increase from a figure that stood at around $13 billion just two years ago.

The platform's portfolio management function supports cross-asset trading, while its order management system enables trading with over 100 executing brokers via direct FIX connections to high-touch, direct market access, and full algo suite destinations.

Trading valuation and risk exposure calculations are managed through a dedicated module that provides a range of tools for risk exposure calculation, portfolio stress-testing, price sourcing, and market data. The platform boasts connectivity tools covering trade affirmation, end-of-day trade delivery, portfolio exports and electronic trade capturing. Integráta also offers its users an end-to-end portfolio management solution, delivered, according to Enfusion, in a manner that does not burden the infrastructure further, a key differentiator when the need for agility and transparency within the capital markets is greater than ever.

Through partnerships with other market players including Omgeo, which has now fully completed its DTCC transition, and London-based data giant, Markit, Enfusion also helps capital market participants comply with regulatory requirements such as mandatory clearing requirements for OTC derivatives as dictated by the Dodd-Frank Act.

For smaller firms to compete in an arena dominated by industry giants, it must be well positioned to provide the right service in the right channels. Enfusion's triumph illustrates that the firm knows what the market wants and has found the winning formula for delivering it.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here